FUNCTIONAL GENOMICS AND CHEMOTHERAPY RESISTANCE SCREENING IDENTIFIES BIOMARKERS AND TARGETABLE MECHANISMS OF CCNU RESISTANCE IN GLIOMAS

被引：0
|
作者：
Hajal, Cynthia [1 ]
Dalin, Simona [1 ]
Raskind, Greg [1 ]
Cusick, Margaret [1 ]
Malinowski, Seth [1 ]
Ito, Jakob [1 ]
Bossi, Connor [1 ]
Vogelzang, Jayne [1 ]
Bellamy, Charlotte [2 ]
Salhi, Lisa [2 ]
Bielle, Franck [3 ]
Getz, Gad [4 ]
Bandopadhayay, Pratiti [1 ]
Touat, Mehdi [5 ]
Beroukhim, Rameen [6 ]
Ligon, Keith [7 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Paris Brain Inst ICM, Paris, France
[3] Hop La Pitie Salpetriere, Paris, France
[4] Broad Inst Harvard & MIT, Boston, MA USA
[5] Hop Univ La Pitie Salpetriere, Paris, France
[6] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
[7] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DDDR-09
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mechanisms of chemotherapy resistance in rhabdomyosarcoma
    Mathavarajah, Sabateeshan
    Wang, Yueyang
    Wei, Yun
    Antelo, Diego
    Langenau, David M.
    CANCER RESEARCH, 2024, 84 (17)
  • [22] Mechanisms of Resistance to Cancer Chemotherapy
    Stefanko, Ewa
    Wrobel, Tomasz
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 19 (01): : 5 - 12
  • [23] Functional Screening in Diploid Yeast Identifies Doxorubicin Resistance Genes Modulated By Estradiol
    Westmoreland, T.
    Danko, M.
    Huper, G.
    Marks, J.
    Bennett, C.
    Olson, J.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 41 - 41
  • [24] MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
    Barbara Oldrini
    Nuria Vaquero-Siguero
    Quanhua Mu
    Paula Kroon
    Ying Zhang
    Marcos Galán-Ganga
    Zhaoshi Bao
    Zheng Wang
    Hanjie Liu
    Jason K. Sa
    Junfei Zhao
    Hoon Kim
    Sandra Rodriguez-Perales
    Do-Hyun Nam
    Roel G. W. Verhaak
    Raul Rabadan
    Tao Jiang
    Jiguang Wang
    Massimo Squatrito
    Nature Communications, 11
  • [25] A FUNCTIONAL GENOMICS APPROACH TO IDENTIFY MECHANISMS OF DRUG RESISTANCE IN SHH MEDULLOBLASTOMA MURINE MODELS
    Bertrand, K. C.
    Faria, C. C.
    Mack, S. C.
    Luck, A. J.
    Wang, X.
    Agnihotri, S.
    Wu, X.
    Garzia, L.
    Smith, C. A.
    Dirks, P. B.
    Taylor, M. D.
    Rutka, J. T.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S179 - S179
  • [26] MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
    Oldrini, Barbara
    Vaquero-Siguero, Nuria
    Mu, Quanhua
    Kroon, Paula
    Zhang, Ying
    Galan-Ganga, Marcos
    Bao, Zhaoshi
    Wang, Zheng
    Liu, Hanjie
    Sa, Jason K.
    Zhao, Junfei
    Kim, Hoon
    Rodriguez-Perales, Sandra
    Nam, Do-Hyun
    Verhaak, Roel G. W.
    Rabadan, Raul
    Jiang, Tao
    Wang, Jiguang
    Squatrito, Massimo
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [27] Cellular resistance mechanisms in cancer and the new approaches to overcome resistance mechanisms chemotherapy
    Al Saihati, Hajir A.
    Rabaan, Ali A.
    SAUDI MEDICAL JOURNAL, 2023, 44 (04) : 329 - 344
  • [28] Dissecting PARP inhibitor resistance with functional genomics
    Pettitt, Stephen J.
    Lord, Christopher J.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2019, 54 : 55 - 63
  • [29] Functional genomics to identify cancer targets and resistance
    Hahn, William C.
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [30] An evolutionary functional genomics approach identifies novel candidate regions involved in isoniazid resistance in Mycobacterium tuberculosis
    Victoria Furió
    Miguel Moreno-Molina
    Álvaro Chiner-Oms
    Luis M. Villamayor
    Manuela Torres-Puente
    Iñaki Comas
    Communications Biology, 4
12345